|
Neoplasia
Citations 1-10 of 4156 total displayed.
|
Most recent content
(15 Oct 2008):
|
Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence
- Jean-Jacques Lataillade, Olivier Pierre-Louis, Hans Carl Hasselbalch, Georges Uzan, Claude Jasmin, Marie-Claire Martyré, and Marie-Caroline Le Bousse-Kerdilès, on behalf of the French INSERM and the European EUMNET Networks on Myelofibrosis
Blood 2008; 112: 3026-3035.
[Abstract]
[Full text]
[PDF]
Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia patients: a population-based study in Sweden
- Sigurdur Y. Kristinsson, Magnus Björkholm, Lynn R. Goldin, Mary L. McMaster, Ingemar Turesson, and Ola Landgren
Blood 2008; 112: 3052-3056.
[Abstract]
[Full text]
[PDF]
Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring
- Ye-Xiong Li, Hui Fang, Qing-Feng Liu, Jiade Lu, Shu-Nan Qi, Hua Wang, Jing Jin, Wei-Hu Wang, Yue-Ping Liu, Yong-Wen Song, Shu-Lian Wang, Xin-Fan Liu, Xiao-Li Feng, and Zi-Hao Yu
Blood 2008; 112: 3057-3064.
[Abstract]
[Full text]
[PDF]
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- Jean-Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret, Pascal Turlure, Nathalie Cambier, Murielle Roussel, Sylvia Bellucci, Bernard Grandchamp, Christine Chomienne, and Pierre Fenaux
Blood 2008; 112: 3065-3072.
[Abstract]
[Full text]
[PDF]
Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation
- Suzanne O. Arulogun, H. Miles Prince, Jonathan Ng, Stephen Lade, Gail F. Ryan, Odette Blewitt, and Christopher McCormack
Blood 2008; 112: 3082-3087.
[Abstract]
[Full text]
[PDF]
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study
- Ken H. Young, Karen Leroy, Michael B. Møller, Gisele W. B. Colleoni, Margarita Sánchez-Beato, Fábio R. Kerbauy, Corinne Haioun, Jens C. Eickhoff, Allen H. Young, Philippe Gaulard, Miguel A. Piris, Terry D. Oberley, William M. Rehrauer, Brad S. Kahl, James S. Malter, Elias Campo, Jan Delabie, Randy D. Gascoyne, Andreas Rosenwald, Lisa Rimsza, James Huang, Rita M. Braziel, Elaine S. Jaffe, Wyndham H. Wilson, Louis M. Staudt, Julie M. Vose, Wing C. Chan, Dennis D. Weisenburger, and Timothy C. Greiner
Blood 2008; 112: 3088-3098.
[Abstract]
[Full text]
[PDF]
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
- Antonio Palumbo, Sara Bringhen, Anna M. Liberati, Tommaso Caravita, Antonietta Falcone, Vincenzo Callea, Marco Montanaro, Roberto Ria, Antonio Capaldi, Renato Zambello, Giulia Benevolo, Daniele Derudas, Fausto Dore, Federica Cavallo, Francesca Gay, Patrizia Falco, Giovannino Ciccone, Pellegrino Musto, Michele Cavo, and Mario Boccadoro
Blood 2008; 112: 3107-3114.
[Abstract]
[Full text]
[PDF]
Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities
- Bart Barlogie, Mauricio Pineda-Roman, Frits van Rhee, Jeff Haessler, Elias Anaissie, Klaus Hollmig, Yazan Alsayed, Sarah Waheed, Nathan Petty, Joshua Epstein, John D. Shaughnessy, Jr, Guido Tricot, Maurizio Zangari, Jerome Zeldis, Sol Barer, and John Crowley
Blood 2008; 112: 3115-3121.
[Abstract]
[Full text]
[PDF]
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
- Derville O'Shea, Ciarán O'Riain, Claire Taylor, Rachel Waters, Emanuela Carlotti, Finlay MacDougall, John Gribben, Andreas Rosenwald, German Ott, Lisa M. Rimsza, Erlend B. Smeland, Nathalie Johnson, Elias Campo, Timothy C. Greiner, Wing C. Chan, Randy D. Gascoyne, George Wright, Louis M. Staudt, T. Andrew Lister, and Jude Fitzgibbon
Blood 2008; 112: 3126-3129.
[Abstract]
[Full text]
[PDF]
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
- Miguel A. Sanz, Pau Montesinos, Edo Vellenga, Consuelo Rayón, Javier de la Serna, Ricardo Parody, Juan M. Bergua, Angel León, Silvia Negri, Marcos González, Concha Rivas, Jordi Esteve, Gustavo Milone, José D. González, Elena Amutio, Salut Brunet, J. García-Laraña, Dolors Colomer, María J. Calasanz, Carmen Chillón, Eva Barragán, Pascual Bolufer, and Bob Lowenberg
Blood 2008; 112: 3130-3134.
[Abstract]
[Full text]
[PDF]
|
|
